310 related articles for article (PubMed ID: 30744931)
21. Multi-Target Directed Drugs as a Modern Approach for Drug Design Towards Alzheimer's Disease: An Update.
de Freitas Silva M; Dias KST; Gontijo VS; Ortiz CJC; Viegas C
Curr Med Chem; 2018; 25(29):3491-3525. PubMed ID: 29332563
[TBL] [Abstract][Full Text] [Related]
22. Multi-Target-Directed Cinnamic Acid Hybrids Targeting Alzheimer's Disease.
Drakontaeidi A; Pontiki E
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203753
[TBL] [Abstract][Full Text] [Related]
23. A comprehensive review of multi-target directed ligands in the treatment of Alzheimer's disease.
Pathak C; Kabra UD
Bioorg Chem; 2024 Mar; 144():107152. PubMed ID: 38290187
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
[TBL] [Abstract][Full Text] [Related]
25. Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease.
Yu YF; Huang YD; Zhang C; Wu XN; Zhou Q; Wu D; Wu Y; Luo HB
ACS Chem Neurosci; 2017 Nov; 8(11):2522-2534. PubMed ID: 28783948
[TBL] [Abstract][Full Text] [Related]
26. Phytochemical profiling and in vitro screening for anticholinesterase, antioxidant, antiglucosidase and neuroprotective effect of three traditional medicinal plants for Alzheimer's Disease and Diabetes Mellitus dual therapy.
Penumala M; Zinka RB; Shaik JB; Mallepalli SKR; Vadde R; Amooru DG
BMC Complement Altern Med; 2018 Mar; 18(1):77. PubMed ID: 29499679
[TBL] [Abstract][Full Text] [Related]
27. [Design of acetylcholinesterase inhibitor for Alzheimer's disease therapy: from multi-binding site inhibitors to multi-target directed ligands].
Yang WC; Sun Q; Yu NX; Zhu XL; Yang GF
Yao Xue Xue Bao; 2012 Mar; 47(3):313-21. PubMed ID: 22645754
[TBL] [Abstract][Full Text] [Related]
28. Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer's disease.
Chioua M; Buzzi E; Moraleda I; Iriepa I; Maj M; Wnorowski A; Giovannini C; Tramarin A; Portali F; Ismaili L; López-Alvarado P; Bolognesi ML; Jóźwiak K; Menéndez JC; Marco-Contelles J; Bartolini M
Eur J Med Chem; 2018 Jul; 155():839-846. PubMed ID: 29958119
[TBL] [Abstract][Full Text] [Related]
29. Tacrine-based Multifunctional Agents in Alzheimer's Disease: An Old Story in Continuous Development§.
Milelli A; De Simone A; Ticchi N; Chen HH; Betari N; Andrisano V; Tumiatti V
Curr Med Chem; 2017; 24(32):3522-3546. PubMed ID: 28294041
[TBL] [Abstract][Full Text] [Related]
30. Multicomponent Reactions for Multitargeted Compounds for Alzheimer`s Disease.
Ismaili L; do Carmo Carreiras M
Curr Top Med Chem; 2017; 17(31):3319-3327. PubMed ID: 29332584
[TBL] [Abstract][Full Text] [Related]
31. Development of novel salicylic acid-donepezil-rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Zhou Y; He Y; Teng X; Mi J; Yang J; Wei R; Liu W; Ma Q; Tan Z; Sang Z
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2231661. PubMed ID: 37414563
[TBL] [Abstract][Full Text] [Related]
32. Design and synthesis of novel anti-Alzheimer's agents: Acridine-chromenone and quinoline-chromenone hybrids.
Najafi Z; Saeedi M; Mahdavi M; Sabourian R; Khanavi M; Tehrani MB; Moghadam FH; Edraki N; Karimpor-Razkenari E; Sharifzadeh M; Foroumadi A; Shafiee A; Akbarzadeh T
Bioorg Chem; 2016 Aug; 67():84-94. PubMed ID: 27289559
[TBL] [Abstract][Full Text] [Related]
33. Triazole derivatives as inhibitors of Alzheimer's disease: Current developments and structure-activity relationships.
Xu M; Peng Y; Zhu L; Wang S; Ji J; Rakesh KP
Eur J Med Chem; 2019 Oct; 180():656-672. PubMed ID: 31352246
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, and evaluation of isoflavone analogs as multifunctional agents for the treatment of Alzheimer's disease.
Wang D; Hu M; Li X; Zhang D; Chen C; Fu J; Shao S; Shi G; Zhou Y; Wu S; Zhang T
Eur J Med Chem; 2019 Apr; 168():207-220. PubMed ID: 30822710
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease.
Keri RS; Quintanova C; Marques SM; Esteves AR; Cardoso SM; Santos MA
Bioorg Med Chem; 2013 Aug; 21(15):4559-69. PubMed ID: 23768661
[TBL] [Abstract][Full Text] [Related]
36. New flavonoid -
Estrada-Valencia M; Herrera-Arozamena C; Pérez C; Viña D; Morales-García JA; Pérez-Castillo A; Ramos E; Romero A; Laurini E; Pricl S; Rodríguez-Franco MI
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):712-727. PubMed ID: 31852270
[TBL] [Abstract][Full Text] [Related]
37. Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer's Disease Treatment.
Dakhlaoui I; Bernard PJ; Pietrzak D; Simakov A; Maj M; Refouvelet B; Béduneau A; Cornu R; Jozwiak K; Chabchoub F; Iriepa I; Martin H; Marco-Contelles J; Ismaili L
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298693
[TBL] [Abstract][Full Text] [Related]
38. A molecular approach in drug development for Alzheimer's disease.
Agatonovic-Kustrin S; Kettle C; Morton DW
Biomed Pharmacother; 2018 Oct; 106():553-565. PubMed ID: 29990843
[TBL] [Abstract][Full Text] [Related]
39. Tacrine-deferiprone hybrids as multi-target-directed metal chelators against Alzheimer's disease: a two-in-one drug.
Chand K; Rajeshwari ; Candeias E; Cardoso SM; Chaves S; Santos MA
Metallomics; 2018 Oct; 10(10):1460-1475. PubMed ID: 30183790
[TBL] [Abstract][Full Text] [Related]
40. Alzheimer's Disease, the "One-Molecule, One-Target" Paradigm, and the Multitarget Directed Ligand Approach.
Oset-Gasque MJ; Marco-Contelles J
ACS Chem Neurosci; 2018 Mar; 9(3):401-403. PubMed ID: 29465220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
